soyasaponin bb has been researched along with soyasapogenol a in 3 studies
Studies (soyasaponin bb) | Trials (soyasaponin bb) | Recent Studies (post-2010) (soyasaponin bb) | Studies (soyasapogenol a) | Trials (soyasapogenol a) | Recent Studies (post-2010) (soyasapogenol a) |
---|---|---|---|---|---|
65 | 1 | 28 | 22 | 0 | 11 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chu, XW; Deng, H; Lu, XC; Luo, HJ; Mao, LM; Sun, SX; Ye, JF; Zha, LY | 1 |
Gurfinkel, DM; Rao, AV; Reynolds, WF | 1 |
Elwakeel, A; Kalra, RS; Kaul, SC; Omar, A; Putri, J; Wadhwa, R | 1 |
3 other study(ies) available for soyasaponin bb and soyasapogenol a
Article | Year |
---|---|
Anti-inflammatory effect of soyasaponins through suppressing nitric oxide production in LPS-stimulated RAW 264.7 cells by attenuation of NF-κB-mediated nitric oxide synthase expression.
Topics: Animals; Anti-Inflammatory Agents; Cell Line, Tumor; Lipopolysaccharides; Mice; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oleanolic Acid; Saponins; Tumor Necrosis Factor-alpha | 2011 |
The isolation of soyasaponins by fractional precipitation, solid phase extraction, and low pressure liquid chromatography.
Topics: Chromatography, Liquid; Fractional Precipitation; Glycine max; Oleanolic Acid; Saponins | 2005 |
Soyasapogenol-A targets CARF and results in suppression of tumor growth and metastasis in p53 compromised cancer cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cyclin-Dependent Kinase Inhibitor p21; Down-Regulation; Female; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Neoplasm Invasiveness; Oleanolic Acid; RNA-Binding Proteins; Saponins; Signal Transduction; Transcriptional Activation; Tumor Suppressor Protein p53; Xenograft Model Antitumor Assays | 2020 |